Bill > HB06919

This bill requires the Connecticut Commissioner of Public Health to update the list of conditions screened in the state's newborn screening program to include Duchenne muscular dystrophy (DMD) by July 1, 2027. Currently, the screening program tests for a variety of genetic and metabolic disorders, including amino acid disorders, hypothyroidism, sickle cell disease, and spinal muscular atrophy, among others. Duchenne muscular dystrophy is a severe genetic disorder that causes progressive muscle weakness and typically affects young boys, leading to significant disability and shortened life expectancy. By adding DMD to the mandatory newborn screening panel, the bill aims to enable earlier detection of the condition, which could potentially allow for earlier intervention, treatment, and family planning. The bill modifies section 19a-55(c) of the Connecticut General Statutes and will become effective on July 1, 2027, following a two-year implementation period.

Budget and Finance, Business and Industry, Health and Social Services

Public Health Committee (J)

https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=HB06919&which_year=2025